
BRIEF-India's Lasa Supergenerics Dec-Quarter Net PAT Rises
Feb 1 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* DEC-QUARTER NET PAT 65.6 MILLION RUPEES VERSUS 25.8 MILLION RUPEES YEAR AGO* DEC-QUARTER REVENUE FROM OPERATIONS 539.9 MILLION RUPEES...
Feb 1 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* DEC-QUARTER NET PAT 65.6 MILLION RUPEES VERSUS 25.8 MILLION RUPEES YEAR AGO* DEC-QUARTER REVENUE FROM OPERATIONS 539.9 MILLION RUPEES...
Mumbai (Maharashtra) [India], January 12 (ANI/NewsVoir): API major, Lasa Supergenerics Ltd. Received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration...
Jan 12 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* GOT WHO NOD FOR ITS UNIT LOCATED AT KHED (RATNAGIRI)...
Nov 24 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* LASA SUPERGENERICS - GOT INJUNCTION FROM COURT RESTRAINING COMPETITOR FROM MANUFACTURING ALBENDAZOLE...
Oct 26 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* SEPT QUARTER NET PAT 70.5 MILLION RUPEES VERSUS LOSS 4.5 MILLION RUPEES YEAR AGO* SEPT QUARTER REVENUE FROM OPERATIONS 546.9 MILLION...
Aug 5 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* JUNE-QUARTER NET PAT 53.7 MILLION RUPEES VERSUS LOSS 10.8 MILLION RUPEES YEAR AGO* JUNE-QUARTER REVENUE FROM OPERATIONS 546 MILLION...
June 10 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* MARCH QUARTER NET PAT 25.8 MILLION RUPEES VERSUS LOSS 18 MILLION RUPEES* MARCH QUARTER REVENUE FROM OPERATIONS 485.9 MILLION RUPEES...
June 5 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* MARCH QUARTER NET PROFIT AFTER TAX 25.8 MILLION RUPEES VERSUS LOSS OF 18 MILLION RUPEES YEAR AGO* MARCH QUARTER REVENUE FROM OPERATIONS...
April 13 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* GETS FDA NOD FOR PROGESTERONE
March 13 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* IMPLEMENTED WORK FROM HOME FOR ALL EMPLOYEES AT HEAD OFFICE IN MUMBAI* WORK FROM HOME ACTION TAKEN TO REDUCE PROBABILITY SPREAD OF...
Feb 10 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* DEC-QUARTER PAT 25.8 MILLION RUPEES VERSUS LOSS OF 52.8 MILLION RUPEES YEAR AGO* DEC-QUARTER REVENUE FROM OPERATIONS 392.9 MILLION...
May 20 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* MARCH QUARTER NET LOSS AFTER TAX 18 MILLION RUPEES VERSUS LOSS 10.3 MILLION RUPEES YEAR AGO* MARCH QUARTER REVENUE FROM OPERATIONS...
Feb 11 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* DEC QUARTER NET LOSS 52.8 MILLION RUPEES VERSUS LOSS 31.1 MILLION RUPEES YEAR AGO* DEC QUARTER REVENUE FROM OPERATIONS 538.8 MILLION...
Aug 13 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* JUNE QUARTER NET LOSS 29.8 MILLION RUPEES VERSUS PROFIT OF 70.4 MILLION RUPEES YEAR AGO* JUNE QUARTER REVENUE FROM OPERATIONS 329.2...
May 2 (Reuters) - Lasa Supergenerics Ltd LASA.NS : * SAYS PRODUCTION RESUMED AS USUAL AT CO'S UNIT POST MAJOR FIRE REPORTED AT MAHAD...
April 27 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* SAYS FIRE INCIDENT IN COMPANY CLOSE TO LASA SUPERGENICS' MAHAD UNIT* SAYS IMPACT OF FIRE ON MAHAD UNIT OPERATIONS IS SEVERE* CO...
April 19 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* SAYS LASA GOT WHO-GMP CERTIFICATE FOR UNIT SITUATED AT MAHAD...
Feb 19 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* TO CONSIDER APPOINTMENT OF HEMA IYER AS CFO...
Jan 31 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* SAYS MINESH CHANDRAKANT BHOSLE RESIGNS AS CFO...
Jan 2 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* SAYS FILED NEW CEP APPLICATION FOR VET API PRODUCT WITH EUROPEAN DIRECTORATE FOR QUALITY OF MEDICINES...
Nov 27 (Reuters) - Lasa Supergenerics Ltd LASA.NS :* BEGINS TRIAL PRODUCTION AT CO'S UNIT IV AT CHIPLUN...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.